Jennison Associates
OM icon

Jennison Associates’s Outset Medical OM Stock Holding History

Jennison Associates’s Portfolio OM Stock Details OM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-50,813
Closed -$8.29M – 614
2023
Q3 		$8.29M Buy
50,813
+839
+2% +$198K 0.01% 382
2023
Q2 		$16.4M Buy
49,974
+9,519
+24% +$2.9M 0.01% 339
2023
Q1 		$11.2M Sell
40,455
-227
-0.6% -$83.3K 0.01% 379
2022
Q4 		$15.8M Sell
40,682
-23,367
-36% -$6.59M 0.02% 352
2022
Q3 		$15.3M Buy
64,049
+1,115
+2% +$299K 0.02% 348
2022
Q2 		$14M Sell
62,934
-32,861
-34% -$14.1M 0.01% 357
2022
Q1 		$65.2M Buy
95,795
+4,614
+5% +$2.78M 0.05% 169
2021
Q4 		$63M Buy
91,181
+23,770
+35% +$17.6M 0.04% 183
2021
Q3 		$50M Buy
67,411
+19,825
+42% +$13.5M 0.03% 218
2021
Q2 		$35.7M Buy
47,586
+6
+0% +$4.59K 0.02% 276
2021
Q1 		$38.8M Buy
47,580
+31,381
+194% +$24.2M 0.03% 253
2020
Q4 		$13.8M Buy
16,199
+1,546
+11% +$1.19M 0.01% 378
2020
Q3 		$11M Buy
+14,653
New +$12M 0.01% 372

Other funds holding OM

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
MIC
Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return

Jennison Associates's OM Position: Q4 2023 in Review

Jennison Associates sold out of Outset Medical (OM) in Q4 2023, closing a stake of 50,813 shares — an estimated $8.29M sold.

Jennison Associates first reported a position in OM in Q3 2020 and held it in 13 quarters. The position peaked at $65.2M in Q1 2022. 140 funds tracked by Wall St. Rank hold OM as of Q4 2023.

  • Jennison Associates reported no remaining Outset Medical position as of Q4 2023 after selling out during the quarter.
  • Jennison Associates sold 50,813 Outset Medical shares in Q4 2023, an estimated $8.29M.
  • Jennison Associates first reported a position in Outset Medical in Q3 2020 and held it in 13 quarters.
  • Jennison Associates's Outset Medical position peaked at $65.2M in Q1 2022.
  • 140 funds tracked by Wall St. Rank held Outset Medical as of Q4 2023.

Based on Jennison Associates's 13F filing for Q4 2023, filed 1 Feb 2024.